z-logo
open-access-imgOpen Access
Long Term Safety and Efficacy of Saroglitazar in Indian Patients with Diabetic Dyslipidemia and Very High Triglyceride Levels: Real World Evidence
Author(s) -
Arjun Baidya
Publication year - 2022
Publication title -
clinical diabetology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.152
H-Index - 4
eISSN - 2450-8187
pISSN - 2450-7458
DOI - 10.5603/dk.a2022.0039
Subject(s) - dyslipidemia , medicine , diabetes mellitus , glycemic , adverse effect , hypertriglyceridemia , triglyceride , creatinine , gastroenterology , endocrinology , cholesterol

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom